Executive
President & CEO
Komei Fukushima
- 1988
- Eisai Co., Ltd.
- 2006
- Eisai Research Institute of Boston, Inc.
- 2014
- Lecturer, Department of Physiology, Keio University School of Medicine
- 2015
- Project Associate Professor, Department of Physiology, Keio University School of Medicine
- 2016
- President and Chief Executive Officer (Representative Director), K Pharma, Inc. (present)
Managing Director & CFO
Masato Matsumoto
- 2001
- PwC Consulting (currently IBM Japan, Ltd.)
- 2005
- Mizuho Investors Securities Co., Ltd. (currently Mizuho Securities Co., Ltd.)
- 2012
- Mizuho Bank, Ltd.
- 2013
- Cross Company (currently Stripe International Inc.)
- 2016
- Director, Stripe International Inc.
- 2021
- Director and Chief Financial Officer, K Pharma Inc.
- 2024
- Managing Director and Chief Financial Officer, K Pharma, Inc. (present)
CSO
Hideyuki Okano
- 1983
- Instructor, Department of Physiology, Keio University School of Medicine
- 1985
- Instructor, Institute for Protein Research, Osaka University
- 1989
- Postdoctoral Research Fellow, Department of Biological Chemistry, The Johns Hopkins University School of Medicine
- 1992
- Instructor, Department of Molecular Neurobiology, Institute of Medical Science, University of Tokyo
- 1994
- Professor, Department of Molecular Neurobiology, Institute of Basic Medical Sciences, University of Tsukuba
- 1997
- Professor, Division of Neuroanatomy, Department of Neuroscience, Osaka University Graduate School of Medicine
- 2001
- Professor, Department of Physiology, Keio University School of Medicine
- 2007
- Dean, Keio University Graduate School of Medicine
- 2008
- Visiting Professor, University of Queensland
- 2014
- Visiting Professor, Hoshi University
- 2015
- Dean, Keio University School of Medicine
- 2019
- Director, K Pharma, Inc. (present)
- 2021
- Visiting Professor, Fujita Health University
- 2022
- Visiting Professor, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology (present)
- 2024
- Distinguished Professor and Director, Keio University Regenerative Medicine Research Center (present)
- 2024
- President, International Society for Stem Cell Research (ISSCR) (present)
CTO
Masaya Nakamura
- 1998
- Research Fellow, Georgetown University
- 2000
- Instructor, Department of Orthopaedic Surgery, Keio University School of Medicine
- 2004
- Assistant professor, Department of Orthopaedic Surgery, Keio University School of Medicine
- 2007
- Lecturer (part-time), Institute for Frontier Medical Sciences, Kyoto University
- 2012
- Associate professor, Department of Orthopaedic Surgery, Keio University School of Medicine
- 2015
- Professor & Chair, Department of Orthopaedic Surgery, Keio University School of Medicine (present)
- 2017
- Assistant Dean, Keio University School of Medicine
- 2019
- Executive Director, The Japanese Society for Regenerative Medicine (JSRM) (present)
- 2019
- Director, K Pharma, Inc. (present)
- 2021
- Vice Dean, Keio University School of Medicine
Outside Director
Miho Yamada
- 1989
- Mitsubishi Corporation's Osaka Branch
- 1992
- Merrill Lynch Securities Tokyo Branch (currently BofA Securities Co., Ltd.)
- 2000
- Merrill Lynch Japan Securities (currently Mitsubishi UFJ Morgan Stanley Securities Co., Ltd.)
- 2009
- Director, Le Credit Trust Co., Ltd.
- 2012
- Outside Director, CBS Financial Services Co., Ltd.
- 2014
- Representative Director, CBS Financial Services Co., Ltd. (present)
- 2025
- Outside Director, K Pharma, Inc. (present)
Outside Audit & Supervisory Board Member (full-time)
Shunsuke Toyokawa
- 1991
- Tsumura & Co.
- 2010
- Director, Head of External Affairs Department, Tsumura & Co.
- 2011
- General Manager, Head of External Affairs Department, Tsumura & Co.
- 2013
- General Manager, Head of Audit & Supervisory Board Office, Tsumura & Co.
- 2017
- General Manager, Head of Audit & Supervisory Committee Office, Tsumura & Co.
- 2017
- General Manager, Internal Auditing Department, Tsumura & Co.
- 2022
- Outside Audit & Supervisory Board Member (full-time), K Pharma, Inc. (present)
Outside Audit & Supervisory Board Member
Yasutaka Nishida
- 2005
- Ernst & Young ShinNihon LLC
- 2012
- President, Accounting Firm (present)
- 2019
- Outside Audit & Supervisory Board Member, K Pharma, Inc. (present)
Outside Audit & Supervisory Board Member
Akiko Isohata
- 2001
- Tokyo Hatchobori Law Office
- 2011
- Partner, Tokyo Hatchobori Law Office (present)
- 2022
- Outside Audit & Supervisory Board Member, NEC Networks & System Integration Corporation
- 2022
- Outside Audit & Supervisory Board Member, K Pharma, Inc. (present)
Director Miho Yamada serves as an Outside Director.
Audit & Supervisory Board Members Shunsuke Toyokawa, Yasutaka Nishida, and Akiko Isohata serve as Outside Audit & Supervisory Board Members.